Skip to main content

Decoding the regulatory genome to deliver first-in-class precision medicines

Biotech TV interview with Nucleome CEO Mark Bodmer, September 2024

In a recent interview with Biotech TV, CEO Mark Bodmer discusses how Nucleome’s unique technology can greatly increase the scale,  precision and capability of genetics-led drug discovery.